| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |